Also, using another oncolytic adenovirus (Delta-24-RGDOX) expressing the co-stimulator OX40 ligand (OX40L) resulted in CD8+ T cell proliferation and cancer-specific immunity in vivo [100]. Here, CD8A is linked to cancer.